Lifecare ASA logo

Lifecare ASA (LFC0)

Market Open
12 Aug, 07:18
XFRA XFRA
0. 03
+0
+3.4483%
11.89M Market Cap
- P/E Ratio
- Div Yield
19,798 Volume
- Eps
0.03
Previous Close
Add Transaction
Day Range
0.03 0.03
Year Range
0.01 1.69
Want to track LFC0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

LFC0 trading today higher at €0.03, an increase of 3.4483% from yesterday's close, completing a monthly increase of 20.4819% or €0.01. Over the past 12 months, LFC0 stock lost -65.9335%.
LFC0 is not paying dividends to its shareholders.
Lifecare ASA has completed 1 stock splits, with the recent split occurring on Oct 01, 2024.
The company's stock is traded on one exchange.

LFC0 Chart

People also search for

DCV
Advanex Inc.
13.2
-2.9412%
OKYO Pharma Limited
1.36
0%
78W
Modulight Oyj
1.04
-0.9524%
3NQ
Nano mRNA Co., Ltd.
0.55
0%
PGT
StrongPoint ASA
0.84
-0.4751%

Lifecare ASA (LFC0) FAQ

What is the stock price today?

The current price is €0.03.

On which exchange is it traded?

Lifecare ASA is listed on XFRA.

What is its stock symbol?

The ticker symbol is LFC0.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 11.89M.

Has Lifecare ASA ever had a stock split?

Lifecare ASA had 1 splits and the recent split was on Oct 01, 2024.

Lifecare ASA Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Joacim Holter CEO
XFRA Exchange
NO0013355859 ISIN
Norway Country
29 Employees
- Last Dividend
1 Oct 2024 Last Split
- IPO Date

Overview

Lifecare AS is a pioneering company based in Bergen, Norway, focused on the innovation and development of advanced medical sensors designed for the health monitoring sector. Since its establishment in 2006, the company has dedicated itself to creating solutions that significantly contribute to the healthcare industry, especially in monitoring chronic conditions such as diabetes. With a strong foundation in research and development, Lifecare AS leverages cutting-edge technology to address the critical needs of patients requiring continuous health monitoring.

Products and Services

  • Sencell

    A revolutionary micro sensor specifically designed for tracking glucose levels in diabetes patients, Sencell represents a significant advancement in diabetes management. This product aims to offer a more seamless and less invasive way for patients to monitor their glucose, providing real-time updates and insights into their condition. By integrating Sencell into their daily lives, individuals with diabetes can achieve better control over their health and lifestyle.

  • Nanostrain Biosensors

    Lifecare's development of nanostrain biosensors showcases its innovative approach to healthcare technology. These biosensors are engineered for the precise measurement of pressure and temperature within live tissue, offering critical data for medical professionals in various therapeutic areas. The application of these biosensors is vast, ranging from monitoring cardiovascular health to tracking the healing progress of internal injuries, thus enabling more personalized and effective treatment plans for patients.

Contact Information

Address: Ytrebygdsvegen 215
Phone: -